跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方萘维新滴眼液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Naphazoline Hydrochloride, Vitamin and Neostigmine Methylsulfate Eye Drops
Approved
化学药品
Compound Naphazoline Hydrochloride, Vitamin and Neostigmine Methylsulfate Eye Drops
山东博士伦福瑞达制药有限公司
🇨🇳 National Medical Products Administration
Approval Date
Nov 24, 2022
Approval ID
7LeafddAP2D
Company
山东博士伦福瑞达制药有限公司
Type
化学药品
Approval Details
Approval Id
7LeafddAP2D
Approval Number
国药准字H20130026
Generic Name
复方萘维新滴眼液
Generic Name En
Compound Naphazoline Hydrochloride, Vitamin and Neostigmine Methylsulfate Eye Drops
Drug Type
化学药品
Dosage Form
滴眼剂
Strength
10ml含盐酸萘甲唑啉0.2mg、维生素B12 2mg、维生素B6 10mg，甲硫酸新斯的明0.2mg、马来酸氯苯那敏1mg，甘草酸二钾10mg和牛磺酸10mg
Reg Date
2022-11-24
Company Name
山东博士伦福瑞达制药有限公司
Company Address
济南市高新技术开发区新泺大街789号
Production Company Name
山东博士伦福瑞达制药有限公司
Production Company Address
济南市高新技术开发区新泺大街789号
Company Detail Path
/organization/shan-dong-bo-shi-lun-fu-rui-da-zhi-yao-you-xian-gong-si
Production Company Detail Path
/organization/shan-dong-bo-shi-lun-fu-rui-da-zhi-yao-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 24, 2022
Approval ID
7LeafddAP2D
Type
化学药品
Back to NMPA Approvals
